Details for 2018743103
Up to date per 30.04.2026
Actions
Details for 2018743103
Granted/Registered
European Patent
06.05.2020 A
05.10.2022 B1
30.06.2017
WO
PCT/JP2017/024211
C07D 223/16 20060101AFI20190104BHEP
Owner
Otsuka Pharmaceutical Co., Ltd.2-9, Kanda Tsukasa-machi Chiyoda-ku Tokyo 101-8535JP
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
KAN, Keizoc/o OTSUKA PHARMACEUTICAL CO., LTD. 3-2-27 Otedori Chuo-ku Osaka-shi Osaka 540-0021JP
TAKUWA, Masatoshic/o OTSUKA PHARMACEUTICAL CO., LTD. 3-2-27 Otedori Chuo-ku Osaka-shi Osaka 540-0021JP
TANAKA, Hirotakac/o OTSUKA PHARMACEUTICALCO., LTD. 3-2-27 Otedori Chuo-ku Osaka-shi Osaka 540-0021JP
FUJIWARA, Hidetoc/o OTSUKA PHARMACEUTICAL CO., LTD. 3-2-27 Otedori Chuo-ku Osaka-shi Osaka 540-0021JP
YAMABE, Hokutoc/o OTSUKA PHARMACEUTICAL CO., LTD. 3-2-27 Otedori Chuo-ku Osaka-shi Osaka 540-0021JP
MATSUDA, Satoshic/o OTSUKA PHARMACEUTICAL CO., LTD. 3-2-27 Otedori Chuo-ku Osaka-shi Osaka 540-0021JP
OHDACHI, Kazuhiroc/o OTSUKA PHARMACEUTICAL CO., LTD. 3-2-27 Otedori Chuo-ku Osaka-shi Osaka 540-0021JP
HANARI, Taikic/o OTSUKA PHARMACEUTICAL CO., LTD. 3-2-27 Otedori Chuo-ku Osaka-shi Osaka 540-0021JP
MENJO, Yasuhiroc/o OTSUKA PHARMACEUTICAL CO., LTD. 3-2-27 Otedori Chuo-ku Osaka-shi Osaka 540-0021JP
URUSHIMA, Tatsuyac/o OTSUKA PHARMACEUTICAL CO., LTD. 3-2-27 Otedori Chuo-ku Osaka-shi Osaka 540-0021JP
FUJITA, Shigekazuc/o OTSUKA PHARMACEUTICAL CO., LTD. 3-2-27 Otedori Chuo-ku Osaka-shi Osaka 540-0021JP
Information about Fees